Recruiting

Observational Study

Sponsor:

UCLA

Code:

NCT06386198

Conditions

Liver Transplant; Complications

Eligibility Criteria

Sex: All

Age: 18 - 25

Healthy Volunteers: Not accepted

Interventions

Health Advocate

Study Details

Brief summary:

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Conditions

Liver Transplant; Complications

Study ID

NCT06386198

Start date

Mar 3, 2024

Status verified date

Aug, 2026

Completion date

Jun 30, 2030

Anticipated

Primary completion date

Jun 30, 2029

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 25

Healthy Volunteers: Not accepted

Inclusion Criteria:

1. Patient has received a liver transplant >1 year ago
2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
3. Patient has an unmet social risk (e.g., food insecurity) or MLVI >/= 2.0.
4. Patient will be transferred to adult transplant team in <6 months.
5. Patient can read and write English or Spanish
6. Patient is between 18-25 years old and can provide informed consent.
7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.

Exclusion Criteria:

  • Patient has significant cognitive impairment.
  • Does not meet age criteria
  • Patient is a ward of the state.
  • Non-English, non-Spanish speakers.
  • Non-US residents.

Study Design

Enrollment

20 participants

Anticipated

Intervention Model

Single group

Primary purpose

Supportive Care

Interventions and Outcome Measures

Arms

experimental: Intervention

This is a single arm pilot intervention.

Interventions

Health Advocate

The Health Advocate intervention will include helping pediatric liver transplant recipients and their families address unmet household social needs (e.g., food insecurity), improve patient-provider communication, and enhance care coordination.

Primary outcome measure

  • Changes in patient experience [ Time Frame: Baseline and 180 days ]

Central Contacts and Locations

Central contacts

Sharad Wadhwani, MD, MPH

510-428-3058sharad.wadhwani@ucsf.edu

Locations

University of California San Francisco

Recruiting

San Francisco, California, United States, 94158

Contacts

Emily Stekol

415-502-3190emily.stekol@ucsf.edu

Principal Investigator:

Sharad Wadhwani, MD, MPH

Children's Healthcare of Atlanta

Recruiting

Atlanta, Georgia, United States, 30345

Contacts

Saira Ali

404-849-3903Saira.ali@choa.org

Principal Investigator:

Nitika Gupta

More Information

Sponsor

University of California, San Francisco

Last update posted

Aug 11, 2026

Last verified

Aug, 2026

Keywords

  • Health Advocate
  • Patient Navigator

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of California, San Francisco on 2026-08-11.